Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse C Nussbaum

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Calcified Tissue International|August 9, 2015
A Case of Hypercalcemia and Overexpression of CYP27B1 in Skeletal Muscle Lesions in a Patient with HIV Infection After Cosmetic Injections with Polymethylmethacrylate (PMMA) for WastingSahar M Hindi, Yongmei Wang, Kirk D Jones, et al.
The Journal of Experimental Medicine|February 20, 2013
Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophagesAri B Molofsky, Jesse C Nussbaum, Hong-Erh Liang, et al.
Immunity|June 21, 2015
Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune PerturbationAri B Molofsky, Frédéric Van Gool, Hong-Erh Liang, et al.
Immunity|May 27, 2019
Tissue-Resident Group 2 Innate Lymphoid Cells Differentiate by Layered Ontogeny and In Situ Perinatal PrimingChristoph Schneider, Jinwoo Lee, Satoshi Koga, et al.
Journal of Clinical Pharmacology|April 23, 2024
Single- and Multiple-Dose Pharmacokinetics of Gefapixant (MK-7264), a P2X3 Receptor Antagonist, in Healthy AdultsJesse C Nussbaum, Azher Hussain, Peter Butera, et al.
AIDS (London, England)|April 25, 2012
A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitisArthur T Jackson, Jesse C Nussbaum, Jacob Phulusa, et al.
Immunity|March 18, 2014
Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cellsSteven J Van Dyken, Alexander Mohapatra, Jesse C Nussbaum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 2009
Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in MalawiJesse C Nussbaum, Arthur Jackson, Dan Namarika, et al.
Nature|September 17, 2013
Type 2 innate lymphoid cells control eosinophil homeostasisJesse C Nussbaum, Steven J Van Dyken, Jakob von Moltke, et al.
Nature Immunology|September 12, 2018
Tissue signals imprint ILC2 identity with anticipatory functionRoberto R Ricardo-Gonzalez, Steven J Van Dyken, Christoph Schneider, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Calcified Tissue International|August 9, 2015
A Case of Hypercalcemia and Overexpression of CYP27B1 in Skeletal Muscle Lesions in a Patient with HIV Infection After Cosmetic Injections with Polymethylmethacrylate (PMMA) for WastingSahar M Hindi, Yongmei Wang, Kirk D Jones, et al.
The Journal of Experimental Medicine|February 20, 2013
Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophagesAri B Molofsky, Jesse C Nussbaum, Hong-Erh Liang, et al.
Immunity|June 21, 2015
Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune PerturbationAri B Molofsky, Frédéric Van Gool, Hong-Erh Liang, et al.
Immunity|May 27, 2019
Tissue-Resident Group 2 Innate Lymphoid Cells Differentiate by Layered Ontogeny and In Situ Perinatal PrimingChristoph Schneider, Jinwoo Lee, Satoshi Koga, et al.
Journal of Clinical Pharmacology|April 23, 2024
Single- and Multiple-Dose Pharmacokinetics of Gefapixant (MK-7264), a P2X3 Receptor Antagonist, in Healthy AdultsJesse C Nussbaum, Azher Hussain, Peter Butera, et al.
AIDS (London, England)|April 25, 2012
A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitisArthur T Jackson, Jesse C Nussbaum, Jacob Phulusa, et al.
Immunity|March 18, 2014
Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cellsSteven J Van Dyken, Alexander Mohapatra, Jesse C Nussbaum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 2009
Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in MalawiJesse C Nussbaum, Arthur Jackson, Dan Namarika, et al.
Nature|September 17, 2013
Type 2 innate lymphoid cells control eosinophil homeostasisJesse C Nussbaum, Steven J Van Dyken, Jakob von Moltke, et al.
Nature Immunology|September 12, 2018
Tissue signals imprint ILC2 identity with anticipatory functionRoberto R Ricardo-Gonzalez, Steven J Van Dyken, Christoph Schneider, et al.
Pageof 3